12 Sep Developing personalized cell therapies to cure disease: Q&A with Jacques Galipeau
Dr Jacques Galipeau
Dr. Jacques Galipeau is the associate dean for therapeutics development and the director of the Program for Advanced Cell Therapy (PACT), a collaboration between UW Health and the University of Wisconsin School of Medicine and Public Health that aims to bring innovative cell therapies to patients. He is also a practicing hematologist, treating patients with blood clot disorders, anemia, and other diseases and conditions.
In 2023, Galipeau was nominated for a Wisconsin Alumni Research Foundation (WARF) Innovation Award for his partnership with Dr. Mahua Dey on a personalized therapeutic cancer vaccine to treat glioblastoma — one of the deadliest forms of cancer. WARF, which serves as the technology transfer office for UW–Madison, has supported faculty across the UW School of Medicine and Public Health through grants, research facilities, and the patenting and licensing of breakthroughs that have benefited the world.